TWD 62.7
(2.96%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -162.73 Million TWD | 0.25% |
2022 | -151.02 Million TWD | 1.66% |
2021 | -153.57 Million TWD | 7.9% |
2020 | -166.74 Million TWD | 22.79% |
2019 | -215.97 Million TWD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -50.46 Million TWD | -2.82% |
2024 Q2 | -14.54 Million TWD | 64.57% |
2023 Q4 | -49.08 Million TWD | -56.66% |
2023 FY | -150.65 Million TWD | 0.25% |
2023 Q3 | -31.33 Million TWD | -42.97% |
2023 Q2 | -21.91 Million TWD | 54.65% |
2023 Q1 | -48.32 Million TWD | 83.01% |
2022 Q4 | -284.49 Million TWD | 0.0% |
2022 FY | -151.02 Million TWD | 1.66% |
2021 FY | -153.57 Million TWD | 7.9% |
2020 FY | -166.74 Million TWD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Allied Biotech Corporation | 88.71 Million TWD | 283.441% |
GeneFerm Biotechnology Co., Ltd. | 153.56 Million TWD | 205.973% |
TTY Biopharm Company Limited | 1.37 Billion TWD | 111.858% |
Synmosa Biopharma Corporation | 614.74 Million TWD | 126.473% |
Orient EuroPharma Co., Ltd. | 84.55 Million TWD | 292.466% |
Center Laboratories, Inc. | -79.26 Million TWD | -105.309% |
Tien Liang BioTech Co., Ltd. | 20.43 Million TWD | 896.33% |
Orient Pharma Co., Ltd. | 27.75 Million TWD | 686.38% |
InnoPharmax Inc. | -64.83 Million TWD | -150.988% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 105.57 Million TWD | 254.15% |
Excelsior Biopharma Inc. | -81.12 Million TWD | -100.594% |
DV Biomed Co., Ltd. | 173.54 Million TWD | 193.771% |
Foresee Pharmaceuticals Co., Ltd. | -1 Billion TWD | 83.849% |
Handa Pharmaceuticals, Inc. | 695.79 Million TWD | 123.389% |
UniPharma Co., Ltd. | -27.3 Million TWD | -496.001% |
Anxo Pharmaceutical Co., Ltd. | 53.15 Million TWD | 406.169% |
Alar Pharmaceuticals Inc. | 385.52 Million TWD | 142.212% |
Winston Medical Supply Co., Ltd. | 196.1 Million TWD | 182.987% |
Mercury Biopharmaceutical Corporation | -45.69 Million TWD | -256.179% |
Bioray Biotech Co., Ltd | -19.33 Million TWD | -741.85% |
TSH Biopharm Corporation Limited | 63.63 Million TWD | 355.757% |